Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis SPDR Series Trust - SPDR S&P Biotech ETF XBI

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests... see more

Opinion & Analysis (ARCA:XBI)

Dow Closes At A New High As Late-Month Rally Boosts Stocks

Benzinga.com  April 30, 2014

10 Bear Market Catalysts To Be On Lookout For…

Benzinga.com  April 29, 2014

ETF Outlook For Wednesday, April 16, 2014 (SMH, IAT, XBI, EWS, INTC, USB)

Benzinga.com  April 16, 2014

Biotechs Struggling To Find A Bottom

Benzinga.com  April 8, 2014

A Tale of Two Headlines

Benzinga.com  April 4, 2014

Despite S&P 500's New High, Stocks Face Challenges

Benzinga.com  April 1, 2014

Biotech ETFs Come Back Down To Earth

Benzinga.com  March 27, 2014

This stealth rally is about to explode into a huge bull market

Dr. George Huang  March 13, 2010

Biotechnology headed for a downturn?

Nick Thomas November 9, 2009

Playing the biotech trend

Tom Dyson July 30, 2009

This sector could produce some triple-digit winners

Tom Dyson June 16, 2009